Differentiation of Progressive Supranuclear Paralysis from Multisystem Atrophy and Parkinson’s Disease by Cranial MRI
Objective: To assess differences in cranial MRI between progressive supranuclear palsy (PSP), multisystem atrophy (MSA) and Parkinson's disease (PD) that support the clinical diagnosis. Background:…Comorbid Parkinson’s disease in a Korean patient with Alexander’s disease
Objective: We report a unique case of genetically diagnosed Alexander's disease comorbid, with clinically diagnosed Parkinson's disease. Background: Alexander disease is a neurological disease, that causes…Risk of Parkinson’s in idiopathic anosmia
Objective: To identify markers of increased risk of Parkinson’s in a cohort of individuals with idiopathic anosmia Background: Smell loss (anosmia) is a common finding…BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease
Objective: We aimed to explore effects of bone marrow stromal cell antigen‐1 (BST1) rs4698412 allelic variant on brain activation and associative clinical symptoms in Parkinson’s…Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS
Objective: To present a case of Parkinson’s disease (PD) complicated by impulse control disorder (ICD) which improved following deep brain stimulation (DBS) targeting the bilateral…Clinical comparison of right onset PD vs left onset PD
Objective: To compare clinical characteristics in right side onset versus left side onset of Parkinson’s disease and evaluate whether side of onset was predictive of…The role of Dopamine in Preparatory Inhibition: What can we learn from Parkinson’s disease?
Objective: Investigating the influence of dopamine on motor inhibition during action preparation. Background: By measuring the amplitude of motor-evoked potentials (MEPs) elicited by transcranial magnetic…Factors associated with dyskinesia in Parkinson’s disease in Mainland China
Objective: To identify the association between dyskinesia and related risk factors, the medication dosage range considered safe and treatment-related variables.To identify the association between dyskinesia…“Best practice” guidelines for the collection and analysis of speech data in patients with Parkinson’s Disease (PD).
Objective: To discuss the literature for collection and analysis of speech data for patients with PD in order to create “best practice” guidelines. Background: Speech…Unilateral increase of blink reflex recovery cycle in drug-naive hemiparkinson syndrome.
Objective: We assessed R2 Blink Reflex Recovery Cycle (R2 BRRC) in drug-naive Parkinson’s disease (PD) patients with unilateral tremor and/or rigidity, diagnosed as hemiparkinson syndrome,…
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 405
- Next Page »